Clinical Trial Update: Study of Idursulfase-beta (GC1111) in Hunter Syndrome [Phase 2]

View source ↗

Summary

Phase 2 study of Idursulfase-beta (GC1111) for Mucopolysaccharidosis II (Hunter syndrome) is being conducted by Green Cross Corporation. The current status of t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Ii

Drugs mentioned

• Idursulfase-beta (idursulfase-beta)

Snippet

Sponsor: Green Cross Corporation | Conditions: Mucopolysaccharidosis II | Phase 2 | Status: UNKNOWN